$80,000 of MEDLINE lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"General issues related to health care and trade policy affecting medical-surgical products and the health care supply chain. General issues related to health care and trade policy affecting medical-surgical products and the health care supply chain. General issues related to health care and trade policy affecting medical-surgical products and the health care supply chain."
You can find more data on corporate lobbying on Quiver Quantitative.
MDLN Insider Trading Activity
MDLN insiders have traded $MDLN stock on the open market 26 times in the past 6 months. Of those trades, 1 have been purchases and 25 have been sales.
Here’s a breakdown of recent trading of $MDLN stock by insiders over the last 6 months:
- 8 HOLDINGS MOZART MANAGER L.L.C. BCP has made 0 purchases and 4 sales selling 33,317,824 shares for an estimated $1,217,349,994.
- MOZART ML-2 HOLDCO L.P. BX has made 0 purchases and 4 sales selling 33,317,824 shares for an estimated $1,217,349,994.
- & FRIEDMAN CAPITAL PARTNERS X (PARALLEL), L.P. HELLMAN has made 0 purchases and 4 sales selling 31,868,237 shares for an estimated $1,164,385,709.
- PRIVATE LTD GIC has made 0 purchases and 11 sales selling 25,117,526 shares for an estimated $879,897,979.
- DOUGLAS P GOLWAS (Chief Commercial Officer) has made 0 purchases and 2 sales selling 100,000 shares for an estimated $3,677,115.
- JESSI L CORCORAN (Principal Accounting Officer) purchased 5,000 shares for an estimated $170,750
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
MDLN Hedge Fund Activity
We have seen 304 institutional investors add shares of MDLN stock to their portfolio, and 137 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CARLYLE GROUP INC. removed 28,219,323 shares (-13.1%) from their portfolio in Q2 2026, for an estimated $1,112,970,099
- INVESCO LTD. added 17,383,322 shares (+82.9%) to their portfolio in Q2 2026, for an estimated $685,598,219
- CAPITAL RESEARCH GLOBAL INVESTORS added 16,802,120 shares (+72.5%) to their portfolio in Q2 2026, for an estimated $662,675,612
- H&F CORPORATE INVESTORS X, LTD. removed 15,599,171 shares (-18.0%) from their portfolio in Q2 2026, for an estimated $615,231,304
- EGERTON CAPITAL (UK) LLP added 12,105,082 shares (+277.3%) to their portfolio in Q2 2026, for an estimated $477,424,434
- FMR LLC added 10,407,002 shares (+28.5%) to their portfolio in Q2 2026, for an estimated $410,452,158
- BLACKROCK, INC. added 9,469,927 shares (+56.0%) to their portfolio in Q2 2026, for an estimated $373,493,920
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
MDLN Analyst Ratings
Wall Street analysts have issued reports on $MDLN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Tigress Financial issued a "Buy" rating on 05/13/2026
To track analyst ratings and price targets for MDLN, check out Quiver Quantitative's $MDLN forecast page.
MDLN Price Targets
Multiple analysts have issued price targets for $MDLN recently. We have seen 7 analysts offer price targets for $MDLN in the last 6 months, with a median target of $54.0.
Here are some recent targets:
- Eric Coldwell from Baird set a target price of $45.0 on 06/03/2026
- Glen Santangelo from Barclays set a target price of $45.0 on 06/01/2026
- Navann Ty from BNP Paribas set a target price of $40.0 on 05/14/2026
- Ivan Feinseth from Tigress Financial set a target price of $62.0 on 05/13/2026
- David Larsen from BTIG set a target price of $55.0 on 05/07/2026
- Lee Hambright from Bernstein set a target price of $54.0 on 05/07/2026
- Patrick Donnelly from Citigroup set a target price of $55.0 on 05/07/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
